Bio Essence Corporation (OTCPK: BIOE)
Health Care · Pharmaceuticals · US
$0.27
— today · +233.8% 1Y
Bio Essence Corporation (OTCPK: BIOE) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $14.37M and employs 4 people.
Over the last twelve months the share price has gained 233.8%, trading between 0.05 and 0.52.
Tweenvest scores Bio Essence Corporation across four factors: quality 43/100, value 30/100, growth 0/100. Its strongest factor is quality.
BIOE price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $14.37M
- Revenue (TTM)
- $2.91M
- P/E
- 7.82
- EPS
- 0.03
- Dividend yield
- —
- Beta (5Y)
- 11.45
- 52-week high
- $0.52
- 52-week low
- $0.05
- Avg volume (3M)
- —
- Shares outstanding
- 53.81M
- Employees
- 4
- Next earnings
- —
About Bio Essence Corporation
Bio Essence Corporation is a global enterprise specializing in herbal health, dietary, and nutritional solutions. It supplies healthcare professionals with a diverse range of herbal remedies, offered in various forms such as granules, capsules, pills, and tablets. Furthermore, the company extends custom formulation and original equipment manufacturing (OEM) services to these practitioners and manufactures and distributes its own line of health supplements. Founded in 2000, Bio Essence Corporation maintains its corporate headquarters in Irvine, California.
- ISIN
- US09090C1053
- Founded
- 2000
- Listed since
- Dec 1, 2022
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Ambee Pharmaceuticals PLCDSE: AMBEEPHA | $14.65M | Tk752.00 | +1.43% |
| Godavari Drugs LimitedBSE: 530317 | $14.65M | Rs140.00 | +18.59% |
| Union Korea Pharm Co., Ltd.KOSDAQ: A080720 | $14.59M | ₩— | — |
| Biofrontera Inc.NasdaqCM: BFRI | $14.41M | $0.97 | -4.43% |
| Lobe Sciences Ltd.CNSX: LOBE | $14.28M | CA$0.06 | +9.09% |
| Lipocine Inc.NasdaqCM: LPCN | $14.18M | $1.72 | -16.10% |
| Panchsheel Organics LimitedBSE: 531726 | $14.04M | Rs103.15 | +0.29% |
| Pharma Equity Group A/SCPSE: PEG | $14.01M | Dkr0.08 | -2.06% |
Figures last refreshed Oct 11, 2026.